Capital is drying up for biotech companies

Just nine biotech companies have listed in the US this year, raising a total of $1bn, according to LifeSci Capital, a boutique investment bank. Almost 60 companies did so in the same period last year, tapping investors for $7.4bn.

Here is much more from the FT.


Comments for this post are closed